Literature DB >> 30902636

A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.

Yunyun Yang1, Liping Li1, Linjie Yuan1, Xiaoying Zhou1, Jianxin Duan2, Hongying Xiao3, Ningning Cai4, Shuai Han1, Xianqiang Ma1, Weidong Liu5, Chun-Chi Chen5, Lingle Wang6, Xin Li3, Jiahuan Chen7, Ning Kang7, Jing Chen7, Zhixun Shen7, Satish R Malwal8, Wanli Liu7, Yan Shi7, Eric Oldfield9, Rey-Ting Guo10, Yonghui Zhang11.   

Abstract

Human Vγ9Vδ2 T cells respond to microbial infections and malignancy by sensing diphosphate-containing metabolites called phosphoantigens, which bind to the intracellular domain of butyrophilin 3A1, triggering extracellular interactions with the Vγ9Vδ2 T cell receptor (TCR). Here, we examined the molecular basis of this "inside-out" triggering mechanism. Crystal structures of intracellular butyrophilin 3A proteins alone or in complex with the potent microbial phosphoantigen HMBPP or a synthetic analog revealed key features of phosphoantigens and butyrophilins required for γδ T cell activation. Analyses with chemical probes and molecular dynamic simulations demonstrated that dimerized intracellular proteins cooperate in sensing HMBPP to enhance the efficiency of γδ T cell activation. HMBPP binding to butyrophilin doubled the binding force between a γδ T cell and a target cell during "outside" signaling, as measured by single-cell force microscopy. Our findings provide insight into the "inside-out" triggering of Vγ9Vδ2 T cell activation by phosphoantigen-bound butyrophilin, facilitating immunotherapeutic drug design.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HMBPP; T cell antigen recognition; Vγ9Vδ2 T cells; allogenic cell therapy; butyrophilin 3A1; cell therapy; immune stimulant; immunotherapy; inside-out signaling; phosphoantigens

Mesh:

Substances:

Year:  2019        PMID: 30902636     DOI: 10.1016/j.immuni.2019.02.016

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  40 in total

1.  Clonal enrichments of Vδ2- γδ T cells in Mycobacterium tuberculosis-infected human lungs.

Authors:  Corinna A Kulicke; Deborah A Lewinsohn; David M Lewinsohn
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

2.  Alpaca (Vicugna pacos), the first nonprimate species with a phosphoantigen-reactive Vγ9Vδ2 T cell subset.

Authors:  Alina S Fichtner; Mohindar M Karunakaran; Siyi Gu; Christopher T Boughter; Marta T Borowska; Lisa Starick; Anna Nöhren; Thomas W Göbel; Erin J Adams; Thomas Herrmann
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-05       Impact factor: 11.205

3.  BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.

Authors:  Kyle K Payne; Jessica A Mine; Subir Biswas; Ricardo A Chaurio; Alfredo Perales-Puchalt; Carmen M Anadon; Tara Lee Costich; Carly M Harro; Jennifer Walrath; Qianqian Ming; Evgenii Tcyganov; Andrea L Buras; Kristen E Rigolizzo; Gunjan Mandal; Jason Lajoie; Michael Ophir; Julia Tchou; Douglas Marchion; Vincent C Luca; Piotr Bobrowicz; Brooke McLaughlin; Ugur Eskiocak; Michael Schmidt; Juan R Cubillos-Ruiz; Paulo C Rodriguez; Dmitry I Gabrilovich; Jose R Conejo-Garcia
Journal:  Science       Date:  2020-08-21       Impact factor: 47.728

Review 4.  Structure-Activity Relationships of Butyrophilin 3 Ligands.

Authors:  Andrew J Wiemer
Journal:  ChemMedChem       Date:  2020-05-26       Impact factor: 3.466

5.  Synthesis and Metabolism of BTN3A1 Ligands: Studies on Diene Modifications to the Phosphoantigen Scaffold.

Authors:  Nyema M Harmon; Michael M Poe; Xueting Huang; Rohit Singh; Benjamin J Foust; Chia-Hung Christine Hsiao; David F Wiemer; Andrew J Wiemer
Journal:  ACS Med Chem Lett       Date:  2022-01-27       Impact factor: 4.345

6.  A luciferase lysis assay reveals in vivo malignant cell sensitization by phosphoantigen prodrugs.

Authors:  Jin Li; Nicholas A Lentini; David F Wiemer; Andrew J Wiemer
Journal:  Biochem Pharmacol       Date:  2019-10-16       Impact factor: 5.858

7.  Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol.

Authors:  Nicholas A Lentini; Chloe M Schroeder; Nyema M Harmon; Xueting Huang; Megan A Schladetsch; Benjamin J Foust; Michael M Poe; Chia-Hung Christine Hsiao; Andrew J Wiemer; David F Wiemer
Journal:  ACS Med Chem Lett       Date:  2020-12-04       Impact factor: 4.345

8.  Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy.

Authors:  Haoting Hsu; Sarah Boudova; Godfrey Mvula; Titus H Divala; David Rach; Randy G Mungwira; Francesca Boldrin; Giulia Degiacomi; Riccardo Manganelli; Miriam K Laufer; Cristiana Cairo
Journal:  Cell Immunol       Date:  2020-11-13       Impact factor: 4.868

9.  Untargeted metabolomics approach to discriminate mistletoe commercial products.

Authors:  Cécile Vanhaverbeke; David Touboul; Nicolas Elie; Martine Prévost; Cécile Meunier; Sylvie Michelland; Valérie Cunin; Ling Ma; David Vermijlen; Cédric Delporte; Stéphanie Pochet; Audrey Le Gouellec; Michel Sève; Pierre Van Antwerpen; Florence Souard
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

10.  Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.

Authors:  Chloé Laplagne; Laetitia Ligat; Juliet Foote; Frederic Lopez; Jean-Jacques Fournié; Camille Laurent; Salvatore Valitutti; Mary Poupot
Journal:  Cell Mol Immunol       Date:  2021-06-28       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.